Alpha 2.0
Login Register
» Articles » PMID: 36697836

Author Correction: The Repertoire of Mutational Signatures in Human Cancer

Overview
Journal Nature
Specialty Science
Date 2023 Jan 25
PMID 36697836
Authors
Ludmil B Alexandrov
Jaegil Kim
Nicholas J Haradhvala
Mi Ni Huang
Alvin Wei Tian Ng
Yang Wu
Arnoud Boot
Kyle R Covington
Dmitry A Gordenin
Erik N Bergstrom
S M Ashiqul Islam
Nuria Lopez-Bigas
Leszek J Klimczak
John R McPherson
Sandro Morganella
Radhakrishnan Sabarinathan
David A Wheeler
Ville Mustonen
Gad Getz
Steven G Rozen
Michael R Stratton
Affiliations
Soon will be listed here.
Citing Articles

Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DC mediated T-cell activation and on-target/off-tumor toxicity.

Rejeski H, Hartz A, Rackl E, Li L, Schwepcke C, Rejeski K Front Immunol. 2025; 15:1527961.

PMID: 39949718 PMC: 11821930. DOI: 10.3389/fimmu.2024.1527961.

Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends.

Thapa B, De Sarkar N, Giri S, Sharma K, Kim M, Kilari D Cancer Manag Res. 2024; 16:1267-1283.

PMID: 39308935 PMC: 11416116. DOI: 10.2147/CMAR.S411023.

Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A.

Harjes S, Kurup H, Rieffer A, Bayarjargal M, Filitcheva J, Su Y Nat Commun. 2023; 14(1):6382.

PMID: 37821454 PMC: 10567711. DOI: 10.1038/s41467-023-42174-w.

Using evolutionary constraint to define novel candidate driver genes in medulloblastoma.

Roy A, Sakthikumar S, Kozyrev S, Nordin J, Pensch R, Makelainen S Proc Natl Acad Sci U S A. 2023; 120(33):e2300984120.

PMID: 37549291 PMC: 10438395. DOI: 10.1073/pnas.2300984120.